Immunisation and screening for cervical cancer is once again under the spotlight as the Ministry of Health and Prevention (MoHAP) recently launched a comprehensive national strategy to combat HPV ...

Dr. Mary Bagita, Coordinator of the Obstetrics and Gynecology (ONG) Division at Port Moresby General Hospital (PMGH), stated that this new facility will be instrumental in reducing the risk of ...

From newly cleared products and implant studies, here are eight updates from spine and orthopedic medtech companies since April 2. 1. Native Orthopaedics earned FDA clearance for its Native root ...

HPV vaccination of boys, pap smear for women from age 25 also part of national strategy Cervical cancer, caused primarily by HPV, ranks as the fifth most common cancer among women in the UAE.

A woman who was diagnosed with cervical cancer following a smear test says accurate data around screening is “absolutely essential” to help save lives. Pamela Orr, a mental health consultant from ...

From acquisitions and new leadership, here are six key updates from spine and orthopedic device companies since March 26: 1. Globus Medical completed its acquisition of Nevro. 2. Smith+Nephew and ...

"Cervical cancer is highly preventable when detected early, and yet, over 4,000 American women will die this year of cervical cancer primarily due to inadequate screening. Our goal is to make HPV ...

For too long, this has been more of a fiction than a reality for too many people. Funded by the Australian Government, ‘Own It’ – the new national cervical screening campaign – was built on this ...

TIVDAK is the first and only ADC to be granted European Union (EU) marketing authorization for people living with recurrent or metastatic cervical cancer. “Recurrent or metastatic cervical cancer is a ...

At-home self-sampling cervical screening looks likely to be an option in the future. But scientists warn that steps must be taken to ensure that the offer of at-home sampling doesn’t have a negative ...